SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Saha Mahasweta)
 

Search: WFRF:(Saha Mahasweta) > Post-treatment symp...

Post-treatment symptomatic improvement of the eastern Indian ADHD probands is influenced by CYP2D6 genetic variations

Chatterjee, Mahasweta (author)
Manovikas Biomedical Research and Diagnostic Centre, Manovikas Kendra, West Bengal, Kolkata, India
Saha, Sharmistha (author)
Manovikas Biomedical Research and Diagnostic Centre, Manovikas Kendra, West Bengal, Kolkata, India
Maitra, Subhamita (author)
Umeå universitet,Diagnostisk radiologi
show more...
Ray, Anirban (author)
Department of Psychiatry, Institute of Psychiatry, Ipgmer, West Bengal, Kolkata, India
Sinha, Swagata (author)
Manovikas Biomedical Research and Diagnostic Centre, Manovikas Kendra, West Bengal, Kolkata, India
Mukhopadhyay, Kanchan (author)
Manovikas Biomedical Research and Diagnostic Centre, Manovikas Kendra, West Bengal, Kolkata, India
show less...
 (creator_code:org_t)
2022-09-28
2023
English.
In: Drug Metabolism and Personalized Therapy. - : Walter de Gruyter. - 2363-8907 .- 2363-8915. ; 38:1, s. 45-56
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Objectives: Symptomatic remediation from attention deficit hyperactivity disorder (ADHD)-associated traits is achieved by treatment with methylphenidate (MPH)/atomoxetine (ATX). We have analyzed the association of functional CYP2D6 variations, rs1065852, rs3892097, rs1135840, and rs1058164, with ADHD in the Indian subjects.Methods: Subjects were recruited following the Diagnostic and Statistical Manual for Mental Disorders. Trait scores were obtained from the Conner's Parents Rating Scale-Revised. After obtaining informed consent, blood was collected for DNA isolation, and genotyping was performed by PCR or TaqMan-based methods. Probands were treated with MPH or ATX based on age, symptoms, and drug availability. Treatment outcome was assessed using a structured questionnaire. Data obtained was analyzed to identify the association of CYP2D6 variations and the SLC6A3 rs28363170 with the treatment outcome.Results: The frequency of rs1135840 "G" and rs1065852 "G" was higher in the male ADHD probands. Bias in parental transmission (p=0.007) and association with higher trait scores were observed for rs1065852 "A". Independent influence of rs1065852 on ADHD was also observed. Probands carrying rs1065852 'GG', rs1135840 'CG', and rs28363170 10R exhibited significant symptomatic improvement with MPH, while probands with rs1135840 'CC' and rs28363170 9R showed improvement after ATX treatment.Conclusions: ADHD probands having specific CYP2D6 genetic variations respond differentially to pharmaceutical intervention.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Psykiatri (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Psychiatry (hsv//eng)

Keyword

atomoxetine (ATX)
attention deficit hyperactivity disorder (ADHD)
CYP2D6
improvement index
methylphenidate (MPH)
SLC6A3
psykiatri
Psychiatry

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view